# Immune Biomarker Study for Head and Neck Cancer

> **NCT05375266** · — · RECRUITING · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 1100 (estimated)

## Conditions studied

- Head and Neck Cancer
- Oral Cavity Cancer
- Oropharyngeal Cancer
- Hypopharyngeal Cancer
- Laryngeal Cancer

## Interventions

- **OTHER:** Sampling

## Key facts

- **NCT ID:** NCT05375266
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-16
- **Primary completion:** 2026-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2023-05-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05375266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05375266, "Immune Biomarker Study for Head and Neck Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05375266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*